IndraLab
Statements
reach
"Our results indicated that knockdown of USP8 or administration of erastin significantly inhibited tumor growth in vivo, erastin treatment and USP8 depletion in combination significantly inhibited tumor growth in vivo than administration of erastin or USP8 depletion alone (Fig. 5L)."
reach
"Immunohistochemistry (IHC) analysis of the expression of prostaglandin-endoperoxide synthase-2 (PTGS2), a marker for the assessment of oxidative stress and ferroptosis in vivo, indicated the combination effect of knocking down USP8 and erastin treatment in triggering tumor ferroptosis in vivo (Fig. 1L)."